WHO's second edition of its dementia risk-reduction guideline, released on 15 July 2026, does not promise that any single lifestyle change will keep a specific person from developing dementia. Instead, it updates the 2019 first edition with a larger evidence base covering 20 modifiable risk factors, up from 12, and grades how confident the science is behind each one — confidence that varies widely from recommendation to recommendation. For adults in midlife, the headline number getting repeated everywhere — up to 45% of dementia risk tied to modifiable factors — describes a population, not a person. Understanding what the guideline actually recommends, and how strongly, matters more than the percentage.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Official resources:
- Read the official guidance from Who — Use this primary source to verify the official guidance.
- Read the official guidance from Who — Use this primary source to verify the official guidance.
Table of Contents
- What the 45% Figure Actually Means
- Which Recommendations Are Strongest, and Which Are Not
- What's New for Midlife Adults Specifically
- What the Guideline Explicitly Does Not Support
- Is This Guideline the Final Word for US Readers?
- Frequently Asked Questions
What the 45% Figure Actually Means
WHO's release accompanying the guideline states that up to 45% of dementia risk is attributable to modifiable factors including tobacco use, alcohol consumption, physical inactivity, social isolation, air pollution, and chronic noncommunicable diseases like diabetes and hypertension. This is a population-attributable fraction — a statistical estimate of how much dementia incidence across an entire population might shift if these factors were eliminated at the population level. It is not a per-person reduction guarantee.
An individual who addresses every modifiable factor on the list does not reduce their own personal risk by 45%. The figure describes what could happen in aggregate, across millions of people, under ideal conditions that no real population fully achieves. This distinction matters because the guideline's own language reflects it: WHO explicitly frames its advice around individualized, multidomain interventions that address at least three relevant risk factors simultaneously, rather than treating any single change as sufficient on its own, according to the guideline itself. No single factor — not diet, not exercise, not hearing aids — is presented as a standalone solution.
Which Recommendations Are Strongest, and Which Are Not
WHO grades every recommendation in two ways: how strong the advice is (strong or conditional) and how certain the underlying evidence is (from very low to moderate or high), using a system called GRADE. These two labels do not always move together, and the gap between them is exactly where overreading happens. The clearest example is physical activity, which carries a strong recommendation backed by moderate-certainty evidence — a notably higher bar than most other items on the list, according to the guideline's executive summary. That combination makes exercise one of the most solidly supported actions in the entire document.
Contrast that with hearing loss. The new edition upgrades hearing loss from "insufficient evidence" in 2019 to a conditional recommendation that adults with hearing loss be offered audiologic rehabilitation, including hearing aids, for possible cognitive-decline and dementia risk reduction. But WHO rates the certainty behind that recommendation as low, per the guideline summary reported by Canadian Audiologist. A conditional recommendation with low certainty is still worth discussing with a clinician — it is not the same tier of evidence as the physical activity recommendation. Reading the grade, not just the recommendation, is how a reader avoids treating a conditional, low-certainty item as settled science.
- Strong + moderate certainty: physical activity
- Conditional + low certainty: hearing rehabilitation for adults with hearing loss, weight management for adults 40-65 with obesity
- Explicit non-recommendation: single-nutrient supplements absent a diagnosed deficiency
What's New for Midlife Adults Specifically
Two additions in the second edition speak directly to adults in their 40s, 50s, and early 60s. First, WHO now makes a conditional recommendation that adults aged 40 to 65 with obesity be offered weight-management and dietary interventions specifically for dementia risk reduction — the first time this age-targeted recommendation has appeared. At the same time, WHO states that evidence directly linking weight management to dementia risk remains limited, according to EMJ Reviews' coverage of the guideline.
Second, the guideline issues its first-ever recommendation on reducing air pollution exposure as part of dementia risk reduction, part of the expansion from 12 to 20 covered risk factors, according to coverage from Medthority. For midlife adults, this reframes air quality — something largely outside individual control — as a legitimate target of risk-reduction policy, not just a lifestyle choice. Both additions share the same shape: a real, newly documented association, paired with an explicit acknowledgment that the evidence is not yet strong enough to call either factor a proven cause of dementia on its own. Readers in this age bracket gain two more documented angles to discuss with a doctor, not two new certainties.
What the Guideline Explicitly Does Not Support
Part of avoiding overreading the headline is noticing what WHO declines to recommend. The guideline advises against taking vitamin B, vitamin E, omega-3 fatty acid, or multivitamin and mineral supplements specifically to reduce dementia risk, unless a person has a diagnosed deficiency, citing a lack of demonstrated benefit and the possibility of harm, according to Medical News Today's coverage. This is a direct recommendation against a common assumption — that supplementing proactively can't hurt.
WHO also states that evidence remains insufficient to recommend specific sleep treatments, post-stroke drugs, post-traumatic-brain-injury interventions, vision treatments, antidepressants, or particular antiretroviral regimens solely as dementia-prevention measures, per Medthority's summary of the guideline. This list matters because all of these areas get discussed informally as dementia-prevention strategies. WHO's position is that the evidence does not yet support recommending them for that specific purpose — a limitation on how far the guideline's claims extend, not a judgment that these treatments lack value for their primary purposes.
Is This Guideline the Final Word for US Readers?
WHO's document is global guidance, built from evidence reviewed for an international audience. The Alzheimer's Association has welcomed the update but is separately developing its own U.S.-focused clinical practice guideline on dementia risk reduction, expected in 2027, according to the Alzheimer's Association's statement.
That means US clinicians and patients should treat the WHO guideline as the current global reference point, not necessarily the last document on this topic. A US-specific version, when it arrives, may weight certain recommendations differently based on domestic population data and healthcare access patterns. Readers who want to act now have a defensible, well-documented starting point; readers who want US-tailored specifics have a reason to watch for next year's release.
Frequently Asked Questions
Does the WHO guideline mean 45% of dementia cases can be prevented in any one person?
No. The 45% figure is a population-level estimate of risk attributable to modifiable factors, not a personal reduction guarantee, according to WHO/PAHO's release.
Should people without a vitamin deficiency take supplements to lower dementia risk?
WHO recommends against taking vitamin B, vitamin E, omega-3, or multivitamin supplements specifically for dementia risk reduction unless a diagnosed deficiency exists.
Are hearing aids now officially recommended for dementia prevention?
WHO issues a conditional recommendation that adults with hearing loss be offered audiologic rehabilitation, including hearing aids, but rates the underlying evidence certainty as low.
Why does obesity treatment now target ages 40 to 65 specifically?
This is the first edition to make an age-targeted conditional recommendation for that group, though WHO notes direct evidence linking weight management to dementia risk is still limited.
You Might Also Like
- Cross-Cultural Dementia Risk Programs After LatAm-FINGERS 2026: How Adults in Midlife Can Avoid Overreading the Headline
- MRI and ARIA Monitoring With At-Home Leqembi in 2026: How People With Early Alzheimer’s Can Compare Treatment Routes
- The Long-Term Care Data Cooperative and Dementia Research in 2026: Who Was Studied and Who Was Not for Adults With Memory Concerns
